Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LANADELUMAB vs LANREOTIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LANADELUMAB vs LANREOTIDE: Safety Overview

Metric LANADELUMAB LANREOTIDE
Total FAERS Reports 2,058 9,007
Deaths Reported 109 1,434
Death Rate 5.3% 15.9%
Hospitalizations 1,007 2,178
Average Patient Age 47.3 yrs 60.2 yrs
% Female Patients 75.7% 53.8%
FDA Approval Date N/A Aug 30, 2007
Manufacturer Takeda Pharmaceuticals America, Inc. Cipla USA Inc.
Route SUBCUTANEOUS SUBCUTANEOUS
Marketing Status N/A Prescription